Kemoplat

Kemoplat

cisplatin

Manufacturer:

Fresenius Kabi

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Cisplatin
Indications/Uses
Alone or in combination for the treatment of metastatic testicular cancer, advanced ovarian carcinoma, advanced bladder carcinoma & squamous cells carcinoma of head & neck.
Dosage/Direction for Use
50-75 mg/m2 as a single IV dose 3-4 wkly or 15-20 mg/m2 IV daily for 5 days 3-4 wkly.
Contraindications
History of hypersensitivity to cisplatin or other platinum-containing compd. Pregnancy, lactation. Renal or hearing impairment, bone marrow depression.
Special Precautions
Monitor hearing function, blood counts, electrolytes, liver function.
Adverse Reactions
Neurotoxicity, ototoxicity, myelosuppression, leukocytopenia, thrombocytopenia, anemia, nausea & vomiting. Electrolyte disturbances, anaphylactic reactions, CV toxicities, hyperuricaemia.
Drug Interactions
Nephrotoxic or ototoxic drugs.
ATC Classification
L01XA01 - cisplatin ; Belongs to the class of platinum-containing antineoplastic agents. Used in the treatment of cancer.
Presentation/Packing
Form
Kemoplat inj 10 mg/20 mL
Packing/Price
1's
Form
Kemoplat inj 50 mg/100 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in